Papers In Press, published online ahead of print October 9, 2007
J. Biol. Chem, 10.1074/jbc.M705812200
Submitted on July 16, 2007
Revised on September 20, 2007
Accepted on October 9, 2007
The human monocytic leukemia zinc-finger histone acetyltransferase domain contains DNA binding activity implicated in chromatin targeting
Marc A. Holbert, Tim Sikorski, Juliana Carten, Daniella Snowflack, Santosh Hodawadekar, and Ronen Marmorstein
The Wistar Institute, Philadelphia, PA 19104
Corresponding Author: marmor{at}wistar.org
The human monocytic leukemia zinc-finger (MOZ) protein is an essential transcriptional coactivator and histone acetyltransferase (HAT) that plays a primary role in the differentiation of erythroid and myeloid cells and that is required to maintain hematopoietic stem cells. Chromosomal translocations involving the HAT-encoded region are also associated with acute myeloid leukemia (AML). Here we present the X-ray crystal structure of the MOZ HAT domain and related biochemical studies. We find that the HAT domain contains a central region that is structurally and functionally conserved with the yeast MYST HAT protein Esa1, but contains more divergent N- and C-terminal regions harboring a TFIIIA-type zinc finger and helix-turn-helix DNA-binding motifs. Solution DNA-binding and acetyltansferase activity assays, in concert with mutagenesis, confirm that the MOZ HAT domain binds strongly to DNA through the zinc finger and helix-turn helix motifs and that DNA binding and catalysis is not mutually exclusive. Consistent with the DNA-binding properties of MOZ, we also show that MOZ is able to acetylate nucleosomes and free histones equally well; while other HATs prefer free histones. Our results reveal, for the first time, that enzymatic and DNA targeting activities can be contained within the same chromatin regulatory domain.